Tianda Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Tianda Pharmaceuticals is a dividend paying company with a current yield of 1.41%.
Key information
1.4%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | 10.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | HK$0.0026 |
Payout ratio | -12% |
Recent dividend and buyback updates
Recent updates
Is Tianda Pharmaceuticals (HKG:455) Weighed On By Its Debt Load?
Dec 10Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop
Oct 28Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected
Aug 16Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?
Jun 20There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump
Mar 27Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)
Mar 02Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?
May 23Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?
Dec 06Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?
Jan 11Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?
Aug 05Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?
Dec 11Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 455 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 455 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
Tianda Pharmaceuticals Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (455) | 1.4% |
Market Bottom 25% (HK) | 3.2% |
Market Top 25% (HK) | 8.0% |
Industry Average (Pharmaceuticals) | 3.8% |
Analyst forecast (455) (up to 3 years) | n/a |
Notable Dividend: 455's dividend (1.41%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.23%).
High Dividend: 455's dividend (1.41%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.04%).
Earnings Payout to Shareholders
Earnings Coverage: 455 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: 455 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 18:32 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianda Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jayaprabha Dhavale | Virtua Research Inc. |